Stockreport

Blacksmith Medicines Announces Upcoming Presentation at AACR Annual Meeting 2024 [Yahoo! Finance]

Cyteir Therapeutics, Inc.  (CYT) 
PDF targeting metalloenzymes, today announced the company will present data on its oncology program targeting flap endonuclease 1 (FEN1), a structure-specific metallonucleas [Read more]